ELV · Elevance Health, Inc. · Webcasts, Transcripts & Audio
$429.69
-0.21 (-0.05%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$92.84B
Shares
216.06M
Volume · Nov 13
779.73K
Avg daily vol (3M)
1.21M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Elevance Health, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Elevance Health, Inc. (ELV), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-11-11
Elevance Health, Inc. (ELV) November 11, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-10-21
Elevance Health, Inc. (ELV) Q3 2026 Earnings Call Transcript
Confident tone
Medicaid margin recovery
Medical cost management
Commercial membership and affordability
Revenue
$51.43B
▲ 1.4% YoY Diluted EPS
$6.27
▲ 17.9% YoY Gross margin
89.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-10
Elevance Health, Inc. (ELV) September 10, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-07-15
Elevance Health, Inc. (ELV) Q2 2026 Earnings Call Transcript
Confident tone
Medicaid Discipline and Market Exits
Raised EPS Guidance and 2027 Growth Outlook
Individual ACA Business
Revenue
$50.47B
▲ 1.4% YoY Diluted EPS
$6.71
▼ 13.1% YoY Gross margin
89.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-10
Elevance Health, Inc. (ELV) June 10, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-04-22
Elevance Health, Inc. (ELV) Q1 2026 Earnings Call Transcript
Confident tone
Medicaid Cost Trend and Behavioral Health Actions
Medicare Advantage Repositioning and 2027 Bid Environment
CMS Risk Adjustment Notice
Revenue
$50.18B
▲ 2.6% YoY Diluted EPS
$8.00
▼ 16.8% YoY Gross margin
89.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-01-28
Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript
Balanced tone
Affordability and cost trend
Carillon and operational execution
EPS guidance and long-term growth target
Revenue
$49.75B*
▲ 9.5% YoY Gross margin
88.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-21
Elevance Health, Inc. (ELV) Q3 2025 Earnings Call Transcript
Cautious tone
Medicaid margin pressure and acuity
2026 planning posture and EPS guidance
Carelon growth and integration
Revenue
$50.71B
▲ 12.4% YoY Diluted EPS
$5.32
▲ 22% YoY Gross margin
89.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-17
Elevance Health, Inc. (ELV) Q2 2025 Earnings Call Transcript
Cautious tone
ACA Marketplace morbidity and pricing
Medicaid rate alignment and membership
Carelon services and Carelon Rx growth
Revenue
$49.78B
▲ 13.4% YoY Diluted EPS
$7.72
▼ 21.6% YoY Gross margin
89.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-22
Elevance Health, Inc. (ELV) Q1 2025 Earnings Call Transcript
Positive tone
Carelon Growth & External Payer Relationships
Membership Growth & Retention
Medicaid Rate Alignment & July Renewals
Revenue
$48.89B
▲ 14.8% YoY Diluted EPS
$9.61
▲ 0.2% YoY Gross margin
89.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-01-23
Elevance Health, Inc. (ELV) Q4 2024 Earnings Call Transcript
Positive tone
Carelon services expansion
Medicare Advantage growth and strategy
Medicaid cost trends and rate sufficiency
Revenue
$45.44B*
▲ 6.6% YoY Gross margin
86.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-17
Elevance Health, Inc. (ELV) Q3 2024 Earnings Call Transcript
Balanced tone
Medicaid acuity-rate mismatch and elevated medical costs
Carelon growth and acquisitions
State partnership and rate recovery over time
Revenue
$45.11B
▲ 5.3% YoY Diluted EPS
$4.36
▼ 20% YoY Gross margin
88.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-17
Elevance Health, Inc. (ELV) Q2 2024 Earnings Call Transcript
Confident tone
CarelonRx investment and integration
Medicare Advantage bids and Star ratings
Carelon Services growth
Revenue
$43.89B
▲ 0.5% YoY Diluted EPS
$9.85
▲ 26.4% YoY Gross margin
89.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-18
Elevance Health, Inc. (ELV) Q1 2024 Earnings Call Transcript
Positive tone
Value-Based Care Partnership with CD&R
Medicare Advantage and Star Ratings
Carelon Growth
Revenue
$42.58B
▲ 1% YoY Diluted EPS
$9.59
▲ 15.5% YoY Gross margin
91.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-01-24
Elevance Health, Inc. (ELV) Q4 2023 Earnings Call Transcript
Confident tone
Carelon Growth and Strategy
Stars and Quality Ratings
Medicare Advantage
Revenue
$42.65B*
▲ 6.8% YoY Gross margin
88.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-18
Elevance Health, Inc. (ELV) Q3 2023 Earnings Call Transcript
Revenue
$42.85B
▲ 7.3% YoY Diluted EPS
$5.45
▼ 17.7% YoY Gross margin
89.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-19
Elevance Health, Inc. (ELV) Q2 2023 Earnings Call Transcript
Revenue
$43.67B
▲ 13% YoY Diluted EPS
$7.79
▲ 15.8% YoY Gross margin
90.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-19
Elevance Health, Inc. (ELV) Q1 2023 Earnings Call Transcript
Revenue
$42.17B
▲ 10.7% YoY Diluted EPS
$8.30
▲ 13.4% YoY Gross margin
91.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-25
Elevance Health, Inc. (ELV) Q4 2022 Earnings Call Transcript
Revenue
$39.93B*
▲ 9.2% YoY Gross margin
90.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-19
Elevance Health, Inc. (ELV) Q3 2022 Earnings Call Transcript
Revenue
$39.94B
▲ 11.5% YoY Diluted EPS
$6.62
▲ 8% YoY Gross margin
91.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-20
Elevance Health, Inc. (ELV) Q2 2022 Earnings Call Transcript
Revenue
$38.63B
▲ 14.1% YoY Diluted EPS
$6.73
▼ 7.2% YoY Gross margin
92.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-20
Elevance Health, Inc. (ELV) Q1 2022 Earnings Call Transcript
Revenue
$38.09B
▲ 17.6% YoY Diluted EPS
$7.32
▲ 9.1% YoY Gross margin
92.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-01-26
Elevance Health, Inc. (ELV) Q4 2021 Earnings Call Transcript
Revenue
$36.58B*
▲ 14.9% YoY Gross margin
91.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-20
Elevance Health, Inc. (ELV) Q3 2021 Earnings Call Transcript
Revenue
$35.82B
▲ 15% YoY Diluted EPS
$6.13
▲ 604.6% YoY Gross margin
91.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-21
Elevance Health, Inc. (ELV) Q2 2021 Earnings Call Transcript
Revenue
$33.85B
▲ 15.7% YoY Diluted EPS
$7.25
▼ 18.6% YoY Gross margin
92.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-21
Elevance Health, Inc. (ELV) Q1 2021 Earnings Call Transcript
Revenue
$32.38B
▲ 9.3% YoY Diluted EPS
$6.71
▲ 13% YoY Gross margin
92.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-01-27
Elevance Health, Inc. (ELV) Q4 2020 Earnings Call Transcript
Revenue
$31.82B
▲ 16.1% YoY Diluted EPS
$2.19
▼ 39.5% YoY Gross margin
92.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-28
Elevance Health, Inc. (ELV) Q3 2020 Earnings Call Transcript
Revenue
$31.16B
▲ 16.8% YoY Diluted EPS
$0.87
▼ 80.9% YoY Gross margin
92.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-29
Elevance Health, Inc. (ELV) Q2 2020 Earnings Call Transcript
Revenue
$29.26B
▲ 14.9% YoY Diluted EPS
$8.91
▲ 104.4% YoY Gross margin
92.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-29
Elevance Health, Inc. (ELV) Q1 2020 Earnings Call Transcript
Revenue
$29.62B
▲ 20.1% YoY Diluted EPS
$5.94
▲ 0.5% YoY Gross margin
93.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-01-29
Elevance Health, Inc. (ELV) Q4 2019 Earnings Call
Revenue
$27.41B
▲ 17.3% YoY Diluted EPS
$3.62
▲ 124.8% YoY Gross margin
95.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–31 of 31 webcasts
Key facts
CIK
1156039
CUSIP
036752103
13F (30d)
1338 filings
1231 filers
Visit website
Investor relations